메뉴 건너뛰기




Volumn 57, Issue 3, 2007, Pages 404-406

Significant drug interaction: Phenytoin toxicity due to erlotinib

Author keywords

Drug interaction; Erlotinib; Non small cell lung cancer; Phenytoin

Indexed keywords

ERLOTINIB; PHENYTOIN;

EID: 34548009373     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2007.02.011     Document Type: Article
Times cited : (31)

References (7)
  • 2
    • 0038726223 scopus 로고    scopus 로고
    • Interactions between antiepileptic and chemotherapeutic drugs
    • Vecht C.J., Wagner G.L., and Wilms E.B. Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 2 7 (2003) 404-409
    • (2003) Lancet Neurol , vol.2 , Issue.7 , pp. 404-409
    • Vecht, C.J.1    Wagner, G.L.2    Wilms, E.B.3
  • 3
    • 10444237217 scopus 로고    scopus 로고
    • Gefetinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity
    • Chiu C.H., Tsai C.M., Chen Y.M., Chiang S.C., Liou J.L., and Perng R.P. Gefetinib is active in patients with brain metastases from non-small cell lung cancer and response is related to skin toxicity. Lung Cancer 47 1 (2005) 129-138
    • (2005) Lung Cancer , vol.47 , Issue.1 , pp. 129-138
    • Chiu, C.H.1    Tsai, C.M.2    Chen, Y.M.3    Chiang, S.C.4    Liou, J.L.5    Perng, R.P.6
  • 4
    • 30844446711 scopus 로고    scopus 로고
    • Complete response to erlotinib treatment in brain metastases from recurrent NSCLC
    • Lai C.S., Boshoff C., Falzon M., and Lee S.M. Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. Thorax 61 1 (2006) 91
    • (2006) Thorax , vol.61 , Issue.1 , pp. 91
    • Lai, C.S.1    Boshoff, C.2    Falzon, M.3    Lee, S.M.4
  • 5
    • 34548018015 scopus 로고    scopus 로고
    • Prod Info Tarceva (TM), 2004.
  • 6
    • 0042234101 scopus 로고    scopus 로고
    • Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports
    • Brickell K., Porter D., and Thompson P. Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports. Br J Cancer 89 4 (2003) 615-616
    • (2003) Br J Cancer , vol.89 , Issue.4 , pp. 615-616
    • Brickell, K.1    Porter, D.2    Thompson, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.